Endogenous Glucagon-like Peptide-1 Suppresses High-Fat Food Intake by Reducing Synaptic Drive onto Mesolimbic Dopamine Neurons.

Glucagon-like peptide-1 (GLP-1) and its analogs act as appetite suppressants and have been proven to be clinically efficacious in reducing body weight in obese individuals. Central GLP-1 is expressed in a small population of brainstem cells located in the nucleus tractus solitarius (NTS), which project to a wide range of brain areas. However, it remains unclear how endogenous GLP-1 released in the brain contributes to appetite regulation. Using chemogenetic tools, we discovered that central GLP-1 acts on the midbrain ventral tegmental area (VTA) and suppresses high-fat food intake. We used integrated pathway tracing and synaptic physiology to further demonstrate that activation of GLP-1 receptors specifically reduces the excitatory synaptic strength of dopamine (DA) neurons within the VTA that project to the nucleus accumbens (NAc) medial shell. These data suggest that GLP-1 released from NTS neurons can reduce highly palatable food intake by suppressing mesolimbic DA signaling.

[1]  C. Strader,et al.  Diet-induced obese mice develop peripheral, but not central, resistance to leptin. , 1997, The Journal of clinical investigation.

[2]  Z. Xu,et al.  Depression of Fast Excitatory Synaptic Transmission in Large Aspiny Neurons of the Neostriatum after Transient Forebrain Ischemia , 2002, The Journal of Neuroscience.

[3]  P. Shughrue,et al.  Distribution of pre‐pro‐glucagon and glucagon‐like peptide‐1 receptor messenger RNAs in the rat central nervous system , 1999, The Journal of comparative neurology.

[4]  B. Chieng,et al.  Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area , 2011, The Journal of physiology.

[5]  H. Grill,et al.  Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  Thomas C. Südhof,et al.  β Phorbol Ester- and Diacylglycerol-Induced Augmentation of Transmitter Release Is Mediated by Munc13s and Not by PKCs , 2002, Cell.

[7]  B. Roth,et al.  Chemogenetic tools to interrogate brain functions. , 2014, Annual review of neuroscience.

[8]  K. Deisseroth,et al.  Input-specific control of reward and aversion in the ventral tegmental area , 2012, Nature.

[9]  J. Hecksher-Sørensen,et al.  The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. , 2014, The Journal of clinical investigation.

[10]  A. Citri,et al.  High on food: the interaction between the neural circuits for feeding and for reward , 2015, Frontiers in Biology.

[11]  R. Seeley,et al.  Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect. , 2014, The Journal of clinical investigation.

[12]  J. Elmquist,et al.  Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice. , 2011, The Journal of clinical investigation.

[13]  S. Dickson,et al.  Gut Peptide GLP-1 and Its Analogue, Exendin-4, Decrease Alcohol Intake and Reward , 2013, PloS one.

[14]  R. North,et al.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs. , 1992, The Journal of physiology.

[15]  D. Drucker,et al.  Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study , 2008, The Lancet.

[16]  A. N. van den Pol,et al.  Glucagon-Like Peptide 1 Excites Hypocretin/Orexin Neurons by Direct and Indirect Mechanisms: Implications for Viscera-Mediated Arousal , 2004, The Journal of Neuroscience.

[17]  R. Stornetta,et al.  Glutamatergic phenotype of glucagon-like peptide 1 neurons in the caudal nucleus of the solitary tract in rats , 2015, Brain Structure and Function.

[18]  S. Lammel,et al.  Projection-Specific Modulation of Dopamine Neuron Synapses by Aversive and Rewarding Stimuli , 2011, Neuron.

[19]  A. Grace,et al.  Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons , 2012, Trends in Neurosciences.

[20]  Filip Bergquist,et al.  The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors , 2012, The Journal of Neuroscience.

[21]  W. Schultz,et al.  Dopamine Modulates the Neural Representation of Subjective Value of Food in Hungry Subjects , 2014, The Journal of Neuroscience.

[22]  W. N. Ross,et al.  Synergistic Release of Ca2+ from IP3-Sensitive Stores Evoked by Synaptic Activation of mGluRs Paired with Backpropagating Action Potentials , 1999, Neuron.

[23]  J. McCutcheon,et al.  Glucagon-Like Peptide-1 Receptor Activation in the Nucleus Accumbens Core Suppresses Feeding by Increasing Glutamatergic AMPA/Kainate Signaling , 2014, The Journal of Neuroscience.

[24]  M. R. Hayes,et al.  GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. , 2012, Endocrinology.

[25]  B. Roth,et al.  Engineered GPCRs as tools to modulate signal transduction. , 2008, Physiology.

[26]  J. D. Hahn,et al.  Hippocampal GLP-1 Receptors Influence Food Intake, Meal Size, and Effort-Based Responding for Food through Volume Transmission , 2015, Neuropsychopharmacology.

[27]  Nora D. Volkow,et al.  Reward, dopamine and the control of food intake: implications for obesity , 2011, Trends in Cognitive Sciences.

[28]  E. Egecioglu,et al.  The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents , 2013, Psychoneuroendocrinology.

[29]  R. Travagli,et al.  Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[30]  T. Elhadd,et al.  Incretin based therapies for type 2 diabetes mellitus. , 2008, Journal of the Indian Medical Association.

[31]  A. Dossat,et al.  Glucagon-Like Peptide 1 Receptors in Nucleus Accumbens Affect Food Intake , 2011, The Journal of Neuroscience.

[32]  B. Roland,et al.  Glucagon‐like peptide‐1 in the rat brain: Distribution of expression and functional implication , 2013, The Journal of comparative neurology.

[33]  M. R. Hayes,et al.  The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors. , 2013, American journal of physiology. Endocrinology and metabolism.

[34]  A. Dossat,et al.  Nucleus accumbens GLP-1 receptors influence meal size and palatability. , 2013, American journal of physiology. Endocrinology and metabolism.

[35]  D O'Shea,et al.  Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. , 1999, Endocrinology.

[36]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[37]  P. Kenny.  Reward Mechanisms in Obesity: New Insights and Future Directions , 2011, Neuron.